Weight loss drugs have become quite popular in the past years. However, there are a few aspects of the drug that need to be ...

Big Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no ...

The late-stage readout suggests that HRS9531 can hold its own against Eli Lilly’s blockbuster GLP-1/GIP agonist Zepbound, ...

According to a new feature by the Washington Post, approximately 16 million American adults are on GLP-1 drugs such as ...

Medication paired with behavioral change support gives employers the opportunity to provide a more well-rounded approach to ...

There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...

GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...

Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study. People with type 2 ...

The molecule, developed in collaboration with Massachusetts-based Kailera Therapeutics, is headed for a new drug application ...

PolyPid's proprietary and clinically validated, prolonged-release drug delivery technology aims to subcutaneously deliver GLP ...

Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, ...

In 568 patients who underwent bariatric surgery, those who also used a GLP-1 receptor agonist during the preoperative and ...